ATL1 and hereditary spastic paraplegia: While the HSP-associated mutation presented here demonstrates a novel gain-of-function disease mechanism in ATL1, a recent study characterized two gain-of-function mutations in ATL3 (Y192C and P338R) that had been identified in hereditary sensory neuropathy patients (38, 39, 60).